Intestinal microbiota in the treatment of metabolically associated fatty liver disease

Metabolically associated fatty liver disease (MAFLD) is a common cause of chronic liver disease, the hepatic manifestation of metabolic syndrome. Despite the increasing incidence of MAFLD, no effective treatment is available. Recent research indicates a link between the intestinal microbiota and liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ji-Shuai, Liu, Jin-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649557/
https://www.ncbi.nlm.nih.gov/pubmed/36387806
http://dx.doi.org/10.12998/wjcc.v10.i31.11240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649557/
https://www.ncbi.nlm.nih.gov/pubmed/36387806
http://dx.doi.org/10.12998/wjcc.v10.i31.11240

Ejemplares similares